Literature DB >> 33656237

Reproducibility of a novel, vacuum-assisted immobilization for breast stereotactic radiotherapy.

James W Snider1, Elizabeth M Nichols2, Yildirim D Mutaf3, Shifeng Chen2, Jason Molitoris2, Tejan Diwanji4, Stewart J Becker2, Steven J Feigenberg5.   

Abstract

A novel, breast-specific stereotactic radiotherapy device has been developed for delivery of highly conformal, accelerated partial breast irradiation. This device employs a unique, vacuum-assisted, breast cup immobilization system that applies a gentle, negative pressure to the target breast with the patient in the prone position. A device-specific patient loader is utilized for simulation scanning and device docking. Prior to clinical activation, a prospective protocol enrolled 25 patients who had been or were to be treated with breast conservation surgery and adjuvant radiotherapy for localized breast cancer. The patients underwent breast cup placement and two separate CT simulation scans. Surgical clips within the breast were mapped and positions measured against the device's integrated stereotactic fiducial/coordinate system to confirm reproducible and durable immobilization during the simulation, treatment planning, and delivery process for the device. Of the enrolled 25 patients, 16 were deemed eligible for analysis. Seventy-three clips (median, 4; mean, 4.6; range, 1-8 per patient) were mapped in these selected patients on both the first and second CT scans. X, Y, and Z coordinates were determined for the center point of each clip. Length of vector change in position was determined for each clip between the two scans. The mean displacement of implanted clips was 1.90 mm (median, 1.47 mm; range, 0.44-6.52 mm) (95% CI, 1.6-2.20 mm). Additional analyses stratified clips by position within the breast and depth into the immobilization cup. Overall, this effort validated the clinically utilized 3-mm planning target volume margin for accurate, reliable, and precise employment of the device.
© 2021 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.

Entities:  

Keywords:  breast cancer; stereotactic radiotherapy

Mesh:

Year:  2021        PMID: 33656237      PMCID: PMC7984473          DOI: 10.1002/acm2.13127

Source DB:  PubMed          Journal:  J Appl Clin Med Phys        ISSN: 1526-9914            Impact factor:   2.102


  25 in total

Review 1.  NIH Consensus Development Conference statement on the treatment of early-stage breast cancer.

Authors: 
Journal:  Oncology (Williston Park)       Date:  1991-02       Impact factor: 2.990

2.  GammaPod-a new device dedicated for stereotactic radiotherapy of breast cancer.

Authors:  Cedric X Yu; Xinyu Shao; Jin Zhang; William Regine; Mike Zheng; Ying S Yu; Jianchun Deng; Zhengcheng Duan
Journal:  Med Phys       Date:  2013-05       Impact factor: 4.071

3.  Commissioning and acceptance guide for the GammaPod.

Authors:  Stewart Becker; Pouya Sabouri; Ying Niu; Karl Prado; Shifeng Chen; Elizabeth Nichols; ByongYong Yi
Journal:  Phys Med Biol       Date:  2019-10-21       Impact factor: 3.609

4.  Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.

Authors:  Jayant S Vaidya; David J Joseph; Jeffrey S Tobias; Max Bulsara; Frederik Wenz; Christobel Saunders; Michael Alvarado; Henrik L Flyger; Samuele Massarut; Wolfgang Eiermann; Mohammed Keshtgar; John Dewar; Uta Kraus-Tiefenbacher; Marc Sütterlin; Laura Esserman; Helle M R Holtveg; Mario Roncadin; Steffi Pigorsch; Marinos Metaxas; Mary Falzon; April Matthews; Tammy Corica; Norman R Williams; Michael Baum
Journal:  Lancet       Date:  2010-07-10       Impact factor: 79.321

5.  The Christie Hospital breast conservation trial: an update at 8 years from inception.

Authors:  G G Ribeiro; B Magee; R Swindell; M Harris; S S Banerjee
Journal:  Clin Oncol (R Coll Radiol)       Date:  1993       Impact factor: 4.126

6.  Ten- to fourteen-year effect of screening on breast cancer mortality.

Authors:  S Shapiro; W Venet; P Strax; L Venet; R Roeser
Journal:  J Natl Cancer Inst       Date:  1982-08       Impact factor: 13.506

7.  Preoperative Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer: Preliminary Results of a Prospective, Phase 2 Trial.

Authors:  Elizabeth Nichols; Susan B Kesmodel; Emily Bellavance; Cynthia Drogula; Katherine Tkaczuk; Randi J Cohen; Wendla Citron; Michelle Morgan; Paul Staats; Steven Feigenberg; William F Regine
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-11-27       Impact factor: 7.038

8.  Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial.

Authors:  Csaba Polgár; János Fodor; Tibor Major; Zoltán Sulyok; Miklós Kásler
Journal:  Radiother Oncol       Date:  2013-06-03       Impact factor: 6.280

9.  Projected Improvements in Accelerated Partial Breast Irradiation Using a Novel Breast Stereotactic Radiotherapy Device: A Dosimetric Analysis.

Authors:  James W Snider; Yildirim Mutaf; Elizabeth Nichols; Andrea Hall; Patrick Vadnais; William F Regine; Steven J Feigenberg
Journal:  Technol Cancer Res Treat       Date:  2017-07-14

10.  Development and validation of a comprehensive patient-specific quality assurance program for a novel stereotactic radiation delivery system for breast lesions.

Authors:  Stewart J Becker; Ying Niu; Yildirim Mutaf; Shifeng Chen; Yannick Poirier; Elizabeth M Nichols; ByongYong Yi
Journal:  J Appl Clin Med Phys       Date:  2019-12       Impact factor: 2.102

View more
  2 in total

1.  Workflow guide to delivering a safe breast treatment using a novel stereotactic radiation delivery system.

Authors:  Elizabeth M Nichols; Mariana Guerrero; Sarah McAvoy; Terri Biggins; ByongYong Yi; Stewart J Becker
Journal:  J Radiosurg SBRT       Date:  2021

2.  Correlation of treatment time to target volume for GammaPod treatments: A simple second calculation.

Authors:  Leah Chen; Stewart J Becker; Sarah Anne McAvoy; Elizabeth M Nichols; Mariana Guerrero
Journal:  J Appl Clin Med Phys       Date:  2022-02-07       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.